U.S. Imaging Services Market Size, Share and Trends 2025 to 2034

What is U.S. Imaging Services Market Size?

The U.S. imaging services market size is estimated at USD 154.11 billion in 2025 and is anticipated to reach around USD 239.07 billion by 2034, expanding at a CAGR of 5.00% from 2025 to 2034.

Market Highlights

• By end user, the hospitals segment will gain a significant market share over the forecast period.
• By modality, the X-ray segment dominated the market in 2024.

Market Size and Forecast

• Market Size in 2025: USD 154.11 Billion
• Market Size in 2026: USD 161.81 Billion
• Forecasted Market Size by 2034: USD 239.07 Billion
• CAGR (2025-2034): 5.00%

MarketOverview

The Medical imaging is the diagnostic technique that provides crucial information with speed, safety, and accuracy. There are different imaging modalities included such as x-ray, ultrasound, MRI Scans, CT scans, and nuclear medicines scans which are the congenital techniques used for the diagnosis of multiple diseases. Moreover, imaging services benefit in early diagnosis of the disease, which helps in positive treatment. Imaging services market growth is attributed to factors including the increasing prevalence of cancer and cardiac disorders with growing awareness about medical imaging technology. For instance, in 2020, a research study of the international agency for cancer research stated that around 2,281,658 new cancer cases were diagnosed in the U.S with 612,390 deaths in the same year. Moreover, the market is estimated to boost owing to the development of various technologies enhancement in medical imaging services.

Market Scope

Market Dynamics

Drivers

Technology advancement in imaging services is estimated to drive the market

The advancement of multiple technologies for improving medical imaging services is estimated to drive market growth. Furthermore, the rising aging population and high prevalence of cancer are the factors that are fueling market growth. The overall growth is projected by factors such as growing funding to support ongoing research activities and increasing private-public initiatives related to medical imaging.

Contrast-enhanced ultrasound and lung CT scans have been extensively utilized in assessing COVID-19 patients during the first and second waves of the pandemic. These modalities were also used with magnetic resonance imaging for the clinical trials of COVID-19 vaccines. However, the overall procedural volume declined due to the cancellation and delay of planned hospital visits.

The lack of skilled technicians is the key factor hampering the growth of the market

The lack of skilled radiologists for non-COVID operations was one of the major factors restraining the market growth. The restrictions in hospital visits and imaging centers drastically reduced the regular imaging procedures including scheduled mammography screenings. The market is expected to witness growth with the adoption of ambulatory imaging centers and teleradiology services.

The rise in the adoption of imaging services in the US is anticipated to drive the market

The use of imaging services is progressively expanding in the U. S. to promote early disease detection, which enhances the disease's treatment possibilities. Additionally, the market is anticipated to grow as non-invasive and affordable procedures are adopted. Medical imaging services take less time than other invasive procedures which shortens hospital stays and thus helps in reducing the cost expenses. Technologies are being developed to improve the image quality that is collected by medical imaging systems. These clear, detailed images aid in early disease diagnosis, which enhances the effectiveness of treatment. Therefore, many medical professionals are adopting medical imaging technologies in imaging services before performing surgeries in order to manage the rising disease burden. To visualize and determine the margins of tumors during surgeries, medical professionals rely on preoperative MRI and CT scans in imaging services.

Medical imaging systems are used by healthcare professionals in interventional radiology to direct minimally invasive surgical operations to treat, detect, and cure multiple illnesses. CT, fluoroscopy, ultrasound, and MRI are types of imaging modalities. When compared to open surgery techniques, minimally invasive surgeries have many advantages, including shorter hospital stays, quicker recovery times, smaller incisions, less discomfort, and reduced scarring. These advantages are anticipated to drive the expansion of the U.S. imaging services market.

Modality Insights

Based on modality, the U.S Imaging services market is segmented into X-rays, CT scans, nuclear medicine scans, ultrasound, MRI scans, and mammography. The X-ray segment holds the largest market share during the forecast period. X-ray is a common primary medical imaging modality for multiple tests and procedures.

This service provides non-invasive disease diagnosis and monitoring, as well as assistance in optimal surgical treatment planning. However, the adoption of this service decreases during the projected period. Since more effective techniques with less related adverse effects are available. Ionizing radiation used in X-ray imaging is toxic and can trigger DNA damage, which can lead to cancer and other diseases.

Additionally, the contrast chemicals used in X-ray imaging may cause different reactions in the body. CT scan, on the other hand, is predicted to expand at the fastest rate during the forecast period. The imaging modality's key advantage is that it allows for detailed imaging of bone, blood vessels, and soft tissues all at once. Furthermore, this service is less expensive and takes less time than other modalities.

End-Use Insights

Based on end-use, the U.S Imaging services market is segmented into hospitals, diagnostic imaging centers, and others. In 2023, the hospitals segment held the largest market share of around 40%. owing to the rise in the prevalence of various conditions such as cancer and cardiac disorders. Furthermore, the availability of several imaging modalities at a single facility and imaging procedure reimbursement policies, are expected to have an impact on overall market growth.

Policies impacting sophisticated diagnostic imaging services such as CT, MRI, PET/CT, and nuclear treatments have been developed by Congress and the Centers for Medicare & Medicaid Services (CMS). Imaging services are covered by Medicare through multiple payment systems, including the Hospital Outpatient Prospective Payment System (HOPPS), the Physician Fee Schedule (PFS), and the Inpatient Prospective Payment System.

U.S. Imaging Services Market Companies

• Alliance Medical Limited
• RadNet, Inc
• InHealth Group
• Sonic Healthcare Limited
• Concordmedical
• RAYUS Radiology
• Medica Trading LLC
• UNILABS
• Novant Health
• Dignity Health
• SimonMed

Segments Covered in the Report

By Modality

• X-rays
• CT scans
• Nuclear medicine scans
• Ultrasound
• Mammography

By End-user

• Hospitals
• Diagnostic Imaging Centers
• Others